Loading...
2CG logo

NanoSphere Health Sciences Inc.DB:2CG Stock Report

Market Cap €127.3k
Share Price
n/a
1Y1,700.0%
7D-35.7%
1D0%
Portfolio Value
View

NanoSphere Health Sciences Inc.

DB:2CG Stock Report

Market Cap: €127.3k

NanoSphere Health Sciences (2CG) Stock Overview

A nano-biotechnology company, focuses on providing biologically active compounds in the United States and Canada. More details

2CG fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health0/6
Dividends0/6

2CG Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

NEW476,058 members

Join community and earn perks

Gain real feedbackFrom our editorial team, personally. Not silence.
Grow your followingReal investors. The kind who actually invest, not scroll past.
Unlock free accessFree premium subscription for consistent and quality authors.
BL
BlackGoat
IN
Investingwilly
RO
RockeTeller
DA
davidlsander
476,058 investors already sharing narratives

NanoSphere Health Sciences Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for NanoSphere Health Sciences
Historical stock prices
Current Share PriceCA$0.009
52 Week HighCA$0.085
52 Week LowCA$0.0005
Beta1.03
1 Month Change20.00%
3 Month Change100.00%
1 Year Change1,700.00%
3 Year Change125.00%
5 Year Change-94.34%
Change since IPO-99.90%

Recent News & Updates

Recent updates

Shareholder Returns

2CGDE PharmaceuticalsDE Market
7D-35.7%3.5%3.0%
1Y1,700.0%45.4%1.8%

Return vs Industry: 2CG exceeded the German Pharmaceuticals industry which returned 43.3% over the past year.

Return vs Market: 2CG exceeded the German Market which returned 0.7% over the past year.

Price Volatility

Is 2CG's price volatile compared to industry and market?
2CG volatility
2CG Average Weekly Movement253.9%
Pharmaceuticals Industry Average Movement5.8%
Market Average Movement5.4%
10% most volatile stocks in DE Market12.8%
10% least volatile stocks in DE Market2.7%

Stable Share Price: 2CG's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: 2CG's weekly volatility has decreased from 2722% to 254% over the past year, but is still higher than 75% of German stocks.

About the Company

FoundedEmployeesCEOWebsite
n/an/an/awww.nanospherehealth.com

NanoSphere Health Sciences Inc., a nano-biotechnology company, focuses on providing biologically active compounds in the United States and Canada. It offers NanoSphere Delivery System, a platform using nanotechnology in the biodelivery of supplements, nutraceuticals, and over-the-counter medications for the cannabis, pharmaceutical, animal health, and other industries. NanoSphere Health Sciences Inc. is headquartered in Vancouver, Canada.

NanoSphere Health Sciences Inc. Fundamentals Summary

How do NanoSphere Health Sciences's earnings and revenue compare to its market cap?
2CG fundamental statistics
Market cap€127.28k
Earnings (TTM)-€73.53k
Revenue (TTM)n/a
0.0x
P/S Ratio
-1.7x
P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
2CG income statement (TTM)
RevenueUS$0
Cost of RevenueUS$0
Gross ProfitUS$0
Other ExpensesUS$84.78k
Earnings-US$84.78k

Last Reported Earnings

Dec 31, 2025

Next Earnings Date

n/a

Earnings per share (EPS)-0.0083
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio-4.7%

How did 2CG perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/07/30 11:41
End of Day Share Price 2026/07/30 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

NanoSphere Health Sciences Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.